Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2011

Mar 21, 2011

34519_dirs_2011-03-21_7fb01289-4e6f-4126-a909-67783fda21e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-03-17

Reporting Person: Tomsche David Scott (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-03-17 Common Stock, par value $0.10 per share P 2000 $3.44 Acquired 32273 Direct
2011-03-17 Common Stock, par value $0.10 per share P 800 $3.50 Acquired 33073 Direct
2011-03-17 Common Stock, par value $0.10 per share P 400 $3.51 Acquired 33473 Direct